The DOI matches its Crossref record; 188 of the 189 references it cites were found in a registry or an index.
Current status of interleukin-10 and regulatory T-cells in cancer
Open accessAbstract
PURPOSE OF REVIEW: Tumor growth elicits antigen-specific cytotoxic as well as immune suppressive responses. Interleukin-10 (IL-10) is a key immune-suppressive cytokine produced by regulatory T-cells and by helper T-cells. Here, we review pleiotropic functions of IL-10 that impact the immune pathology of cancer. RECENT FINDINGS: The role of IL-10 in cancer has become less certain with the knowledge of its immune stimulatory functions. IL-10 is needed for T-helper cell functions, T-cell immune surveillance, and suppression of cancer-associated inflammation. By promoting tumor-specific immune surveillance and hindering pathogenic inflammation, IL-10 is emerging as a key cytokine in the battle of the host against cancer. SUMMARY: IL-10 functions at the cross-roads of immune stimulation and immune suppression in cancer. Immunological mechanisms of action of IL-10 can be ultimately exploited to develop novel and effective cancer therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cancer cells also directly inhibit the immune system through molecules like vascular endothelial growth factor (VEGF), prostaglandin E2, transforming growth factor-β (TGF- β), and interleukin-10 (IL-10), which suppress cytotoxic T-cell function [77,78,80,81,82,83].”
From Current and Future Trends of Colorectal Cancer Treatment: Exploring Advances in Immunotherapy (2024) · cites this paper as [83]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
Park, J., Adoro, S., Guinter, T. I., Erman, B., Alag, A., Catálfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608 · cited 1×
“The concepts of T-cell help [5] and natural tolerance induced by regulatory T-cells (Tregs) [6] were both established after the discovery of tumor antigens, and provided additional knowledge of mechanisms that promote or hinder cancer immune surveillance.”
BackgroundIvanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene
Duerr, R. H., Taylor, K. D., Brant, S. R., Rioux, J. D., Silverberg, M. S., Daly, M. J., Steinhart, A. H., Abraham, C., Regueiro, M., Griffiths, A., et al. (2006) · Science · doi:10.1126/science.1135245 · Cited by 3,039
IL-10 inhibits cytokine production by activated macrophages
Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M., & O’Garra, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.11.3815 · Cited by 2,888
Fiorentino, D. F., Bond, M. W., & Mosmann, T. R. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.170.6.2081 · Cited by 2,733
Toll Pathway-Dependent Blockade of CD4 + CD25 + T Cell-Mediated Suppression by Dendritic Cells
Pasare, C., & Medzhitov, R. M. (2003) · Science · doi:10.1126/science.1078231 · Cited by 2,000
Terzić, J., Grivennikov, S., Karin, E., & Karin, M. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.058 · Cited by 1,974
Ghiringhelli, F., Apetoh, L., Tesniere, A., Aymeric, L., Ma, Y., Ortiz, C., Vermaelen, K., Panaretakis, T., Mignot, G., Ullrich, E., et al. (2009) · Nature Medicine · doi:10.1038/nm.2028 · Cited by 1,898
Moore, K. W., O’Garra, A., Malefyt, R. D. W., Vieira, P., & Mosmann, T. R. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.001121 · Cited by 1,883
Rioux, J. D., Xavier, R. J., Taylor, K. D., Silverberg, M. S., Goyette, P., Huett, A., Green, T., Kuballa, P., Barmada, M. M., Datta, L. W., et al. (2007) · Nature Genetics · doi:10.1038/ng2032 · Cited by 1,769
B cells regulate autoimmunity by provision of IL-10
Fillatreau, S., Sweenie, C. H., McGeachy, M. J., Gray, D., & Anderton, S. M. (2002) · Nature Immunology · doi:10.1038/ni833 · Cited by 1,647
CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes
Janssen, E. M., Lemmens, E. E., Wolfe, T., Christen, U., von Herrath, M. G., & Schoenberger, S. P. (2003) · Nature · doi:10.1038/nature01441 · Cited by 1,635
Asseman, C., Mauze, S., Leach, M. W., Coffman, R. L., & Powrie, F. M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.7.995 · Cited by 1,617
T Helper 17 Lineage Differentiation Is Programmed by Orphan Nuclear Receptors RORα and RORγ
Yang, X. O., Pappu, B. P., Nurieva, R., Akimzhanov, A., Kang, H. S., Chung, Y., Ma, L., Shah, B., Panopoulos, A. D., Schluns, K. S., et al. (2008) · Immunity · doi:10.1016/j.immuni.2007.11.016 · Cited by 1,605
Regulatory T Cell-Derived Interleukin-10 Limits Inflammation at Environmental Interfaces
Rubtsov, Y. P., Rasmussen, J. P., Chi, E. Y., Fontenot, J., Castelli, L., Ye, X., Treuting, P., Siewe, L., Roers, A., Henderson, W. R., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.02.017 · Cited by 1,586
Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell Memory
Shedlock, D. J., & Shen, H. (2003) · Science · doi:10.1126/science.1082305 · Cited by 1,450
Adenoma–linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth
Grivennikov, S. I., Wang, K., Mucida, D., Stewart, C. A., Schnabl, B., Jauch, D., Taniguchi, K., Yu, G.-Y., Österreicher, C. H., Hung, K. E., et al. (2012) · Nature · doi:10.1038/nature11465 · Cited by 1,327
Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity
Curiel, T. J., Wei, S., Dong, H., Alvarez, X., Cheng, P., Mottram, P., Krzysiek, R., Knutson, K. L., Daniel, B., Zimmermann, M. C., et al. (2003) · Nature Medicine · doi:10.1038/nm863 · Cited by 1,314
Defective CD8 T Cell Memory Following Acute Infection Without CD4 T Cell Help
Sun, J. C., & Bevan, M. J. (2003) · Science · doi:10.1126/science.1083317 · Cited by 1,213
Interleukin‐10‐secreting type 1 regulatory T cells in rodents and humans
Roncarolo, M. G., Gregori, S., Battaglia, M., Bacchetta, R., Fleischhauer, K., & Levings, M. K. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00420.x · Cited by 1,206
Akbari, O., DeKruyff, R. H., & Umetsu, D. T. (2001) · Nature Immunology · doi:10.1038/90667 · Cited by 1,196
Regulatory T cells in the control of immune pathology
Maloy, K. J., & Powrie, F. M. (2001) · Nature Immunology · doi:10.1038/ni0901-816 · Cited by 1,177
Tosolini, M., Kirilovsky, A., Mlecnik, B., Fredriksen, T., Mauger, S., Bindea, G., Berger, A., Bruneval, P., Fridman, W.-H., Pagès, F., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2907 · Cited by 1,146
Dardalhon, V., Awasthi, A., Kwon, H., Galileos, G., Gao, W., Sobel, R. A., Mitsdoerffer, M., Strom, T. B., Elyaman, W., Ho, I.-C., et al. (2008) · Nature Immunology · doi:10.1038/ni.1677 · Cited by 1,122
Th17 and regulatory T cells in mediating and restraining inflammation
Littman, D. R., & Rudensky, A. Y. (2010) · Cell · doi:10.1016/j.cell.2010.02.021 · Cited by 1,039
Salama, P. R., Phillips, M. R., Grieu, F., Morris, M. J., Zeps, N., Joseph, D. J., Platell, C. F. E., & Iacopetta, B. J. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.7229 · Cited by 1,025
TGF-β1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells
Marie, J. C., Letterio, J. J., Gavin, M. A., & Rudensky, A. Y. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042276 · Cited by 986
Chaudhry, A., Samstein, R. M., Treuting, P., Liang, Y., Pils, M. C., Heinrich, J.-M., Jack, R. S., Wunderlich, F. T., Brüning, J. C., Müller, W., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.03.018 · Cited by 980
Interleukin-10 Therapy—Review of a New Approach
Asadullah, K., Sterry, W., & Volk, H. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.2.4 · Cited by 941
Prete, G. D., Carli, M., Almerigogna, F., Giudizi, M. G., Biagiotti, R., & Romagnani, S. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.2.353 · Cited by 927
Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells
Groux, H., Bigler, M., de Vries, J. D., & Roncarolo, M. (1996) · Journal of Experimental Medicine · doi:10.1084/jem.184.1.19 · Cited by 876
Tumor-specific Th17-polarized cells eradicate large established melanoma
Muranski, P. J., Boni, A., Antony, P. A., Cassard, L., Irvine, K. R., Kaiser, A., Paulos, C. M., Palmer, D. C., Touloukian, C. E., Ptak, K., et al. (2008) · Blood · doi:10.1182/blood-2007-11-120998 · Cited by 864
Prevention of Arthritis by Interleukin 10–producing B Cells
Mauri, C., Gray, D., Mushtaq, N., & Londei, M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021293 · Cited by 858
Murai, M., Turovskaya, O., Kim, G., Madan, R., Karp, C. L., Cheroutre, H., & Kronenberg, M. (2009) · Nature Immunology · doi:10.1038/ni.1791 · Cited by 851
SOCS3 negatively regulates IL-6 signaling in vivo
Croker, B. A., Krebs, D. L., Zhang, J.-G., Wormald, S., Willson, T. A., Stanley, E. G., Robb, L., Greenhalgh, C. J., Förster, I., Clausen, B. E., et al. (2003) · Nature Immunology · doi:10.1038/ni931 · Cited by 840
T Helper 17 Cells Promote Cytotoxic T Cell Activation in Tumor Immunity
Martín‐Orozco, N., Muranski, P. J., Chung, Y., Yang, X. O., Yamazaki, T., Lu, S., Hwu, P., Restifo, N. P., Overwijk, W. W., & Dong, C. (2009) · Immunity · doi:10.1016/j.immuni.2009.09.014 · Cited by 829
HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help
Grakoui, A., Shoukry, N. H., Woollard, D. J., Han, J., Hanson, H. L., Ghrayeb, J., Murthy, K. K., Rice, C. M., & Walker, C. M. (2003) · Science · doi:10.1126/science.1088774 · Cited by 824
Roncarolo, M. G., Bacchetta, R., Bordignon, C., Narula, S. K., & Levings, M. K. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1820105.x · Cited by 814
Awasthi, A., Carrier, Y., Peron, J. P. S., Bettelli, E., Kamanaka, M., Flavell, R. A., Kuchroo, V. K., Oukka, M., & Weiner, H. L. (2007) · Nature Immunology · doi:10.1038/ni1541 · Cited by 804
Wakkach, A., Fournier, N., Brun, V., Breittmayer, J., Cottrez, F., & Groux, H. (2003) · Immunity · doi:10.1016/s1074-7613(03)00113-4 · Cited by 788
Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10
Stumhofer, J. S., Silver, J. S., Laurence, A. D. J., Porrett, P. M., Harris, T. H., Turka, L. A., Ernst, M., Saris, C. J. M., O’Shea, J. J., & Hunter, C. A. (2007) · Nature Immunology · doi:10.1038/ni1537 · Cited by 777
Vieira, P., Malefyt, R. D. W., Dang, M. N., Johnson, K. E., KASTELEIN, R. A., Fiorentino, D. F., Devriès, J., Roncarolo, M., Mosmann, T. R., & Moore, K. W. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.4.1172 · Cited by 740
CD4+CD25+ TR Cells Suppress Innate Immune Pathology Through Cytokine-dependent Mechanisms
Maloy, K. J., Salaün, L., Cahill, R., Dougan, G., Saunders, N. J. S. G., & Powrie, F. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021345 · Cited by 740
Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells
Chen, Z. J., Laurence, A. D. J., Kanno, Y., Pacher-Zavisin, M. C., Zhu, B., Tato, C. M., Yoshimura, A., Hennighausen, L. G., & O’Shea, J. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600666103 · Cited by 663
Control of TH17 cells occurs in the small intestine
Esplugues, E., Huber, S., Gagliani, N., Hauser, A. E., Town, T., Wan, Y. Y., O’Connor, W., Rongvaux, A., van Rooijen, N., Haberman, A. M., et al. (2011) · Nature · doi:10.1038/nature10228 · Cited by 660
Prognostic Value of Tumor-Infiltrating CD4+ T-Cell Subpopulations in Head and Neck Cancers
Badoual, C., Hans, S., Rodriguez, J., Peyrard, S., Klein, C., Agueznay, N. E. H., Mosseri, V., Laccourreye, O., Bruneval, P., Fridman, W. H., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1886 · Cited by 630
Shaping Gene Expression in Activated and Resting Primary Macrophages by IL-10
Lang, R., Patel, D. H., Morris, J. J., Rutschman, R., & Murray, P. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.5.2253 · Cited by 621
McGuirk, P., McCann, C., & Mills, K. H. G. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011288 · Cited by 617
TH1 cells control themselves by producing interleukin-10
O’Garra, A., & Vieira, P. (2007) · Nature reviews. Immunology · doi:10.1038/nri2097 · Cited by 614
Malefyt, R. D. W., Yssel, H., & de Vries, J. E. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.11.4754 · Cited by 610
Huber, S., Gagliani, N., Esplugues, E., O'Connor, W., Huber, F. J., Chaudhry, A., Kamanaka, M., Kobayashi, Y., Booth, C. J., Rudensky, A. Y., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.01.020 · Cited by 602
Maynard, C. L., Harrington, L. E., Janowski, K. M., Oliver, J. R., Zindl, C. L., Rudensky, A. Y., & Weaver, C. T. (2007) · Nature Immunology · doi:10.1038/ni1504 · Cited by 599
IFN-α and IL-10 Induce the Differentiation of Human Type 1 T Regulatory Cells
Levings, M. K., Sangregorio, R., Galbiati, F., Squadrone, S., Malefyt, R. D. W., & Roncarolo, M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.9.5530 · Cited by 595
Jankovic, D. L., Kullberg, M. C., Feng, C. G., Goldszmid, R. S., Collazo, C. M., Wilson, M. D., Wynn, T. A., Kamanaka, M., Flavell, R. A., & Sher, A. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062175 · Cited by 590
Anderson, C. F., Oukka, M., Kuchroo, V. K., & Sacks, D. L. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061886 · Cited by 571
How Tolerogenic Dendritic Cells Induce Regulatory T Cells
Maldonado, R., & von Andrian, U. H. (2010) · Advances in immunology · doi:10.1016/b978-0-12-380995-7.00004-5 · Cited by 566
Two Functional Subsets of FOXP3+ Regulatory T Cells in Human Thymus and Periphery
Ito, T., Hanabuchi, S., Wang, Y.-H., Park, W. R., Arima, K., Bover, L. C., Qin, F. X.-F., Gilliet, M. F., & Liu, Y. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.018 · Cited by 565
Belkaid, Y., Hoffmann, K. F., Mendez, S., Kamhawi, S., Udey, M. C., Wynn, T. A., & Sacks, D. L. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.10.1497 · Cited by 557
IL-10–producing and naturally occurring CD4+ Tregs: limiting collateral damage
O’Garra, A., Vieira, P. L., Vieira, P., & Goldfeld, A. E. (2004) · Journal of Clinical Investigation · doi:10.1172/jci23215 · Cited by 530
Fitzgerald, D. C., Zhang, G.-X., El-Behi, M., Fonseca-Kelly, Z., Li, H., Yu, S., Saris, C. J. M., Gran, B., Ciric, B., & Rostami, A. (2007) · Nature Immunology · doi:10.1038/ni1540 · Cited by 529
Ly‐1 B (B‐1) cells are the main source of B cell‐derived interleukin 10
O’Garra, A., Chang, R., Go, N. F., Hastings, R., Haughton, G., & Howard, M. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220314 · Cited by 525
Steinbrink, K., Jonuleit, H., Müller, G., Schuler, G., Knop, J., & Enk, A. (1999) · Blood · doi:10.1182/blood.v93.5.1634 · Cited by 509
Nosho, K., Baba, Y., Tanaka, N., Shima, K., Hayashi, M., Meyerhardt, J. A., Giovannucci, E., Dranoff, G., Fuchs, C. S., & Ogino, S. (2010) · The Journal of Pathology · doi:10.1002/path.2774 · Cited by 502
Pot, C., Jin, H., Awasthi, A., Liu, S. M., Lai, C.-Y., Madan, R., Sharpe, A. H., Karp, C. L., Miaw, S., Ho, I., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901233 · Cited by 480
Go, N. F., Castle, B. E., Barrett, R., KASTELEIN, R. A., Dang, W., Mosmann, T. R., Moore, K. W., & Howard, M. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.172.6.1625 · Cited by 475
Dillon, S. M., Agrawal, A., Dyke, T. E. V., Landreth, G. E., McCauley, L. K., Koh, A. J., Maliszewski, C. R., Akira, S., & Pulendran, B. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.8.4733 · Cited by 469
Stolina, M., Sharma, S. P., Lin, Y., Dohadwala, M., Gardner, B. K., Luo, J., Zhu, L. X., Kronenberg, M., Miller, P. W., Portanova, J. P., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.361 · Cited by 465
Steinbrink, K., Graulich, E., Kubsch, S., Knop, J., & Enk, A. (2002) · Blood · doi:10.1182/blood.v99.7.2468 · Cited by 448
Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response
MURRAY, P. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.01.010 · Cited by 436
Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment
Gajewski, T. F., Woo, S., Zha, Y., Spaapen, R. M., Zheng, Y., Corrales, L. P., & Spranger, S. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.02.009 · Cited by 429
Recombinant Human IL-10 Prevents the Onset of Diabetes in the Nonobese Diabetic Mouse
Pennline, K. J., Roque-Gaffney, E., & Monahan, M. (1994) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1994.1068 · Cited by 428
The Role of IL-10 and TGF-β in the Differentiation and Effector Function of T Regulatory Cells
Levings, M. K., Bacchetta, R., Schulz, U., & Roncarolo, M. G. (2002) · International Archives of Allergy and Immunology · doi:10.1159/000067596 · Cited by 423
IL-10 Elicits IFNγ-Dependent Tumor Immune Surveillance
Mumm, J. B., Emmerich, J., Zhang, X., Chan, I., Wu, L., Mauze, S., Blaisdell, S., Basham, B., Dai, J., Grein, J., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.11.003 · Cited by 418
Diversity in the contribution of interleukin‐10 to T‐cell‐mediated immune regulation
Maynard, C. L., & Weaver, C. T. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00711.x · Cited by 413
Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis
Scott-Browne, J. P., Shafiani, S., Tucker-Heard, G., Ishida-Tsubota, K., Fontenot, J. D., Rudensky, A. Y., Bevan, M. J., & Urdahl, K. B. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062105 · Cited by 408
Interleukin-10 and the immune response against cancer: a counterpoint
D, S. M. M., Marincola, F. M., & Young, H. A. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0705358 · Cited by 407
Murray, P. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500419102 · Cited by 395
Kamanaka, M., Kim, S. T., Wan, Y. Y., Sutterwala, F. S., Lara-Tejero, M., Galán, J. E., Harhaj, E., & Flavell, R. A. (2006) · Immunity · doi:10.1016/j.immuni.2006.09.013 · Cited by 392
IL-10: a novel cytotoxic T cell differentiation factor
Chen, W. F., & Zlotnik, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.2.528 · Cited by 385
Mechanisms of interleukin‐10‐mediated immune suppression
Akdiş, C. A., & Blaser, K. (2001) · Immunology · doi:10.1046/j.1365-2567.2001.01235.x · Cited by 381
Mucida, D., Husain, M. M., Muroi, S., van Wijk, F., Shinnakasu, R., Naoe, Y., Reis, B. S., Huang, Y., Lambolez, F., Docherty, M., et al. (2013) · Nature Immunology · doi:10.1038/ni.2523 · Cited by 376
Interleukin-10 production by effector T cells: Th1 cells show self control
Trinchieri, G. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070104 · Cited by 373
Inhibitory and Stimulatory Effects of IL-10 on Human CD8+ T Cells
Groux, H., Bigler, M., de Vries, J. E., & Roncarolo, M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.7.3188 · Cited by 373
IL-10, a novel growth cofactor for mature and immature T cells.
MacNeil, I. A., Suda, T., Moore, K. W., Mosmann, T. R., & Zlotnik, A. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.12.4167 · Cited by 360
Frey, D. M., Droeser, R. A., Viehl, C. T., Zlobec, I., Lugli, A., Zingg, U., Oertli, D., Kettelhack, C., Terracciano, L., & Tornillo, L. (2009) · International Journal of Cancer · doi:10.1002/ijc.24989 · Cited by 351
Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10
O’Garra, A., Stapleton, G., Dhar, V., Pearce, M. K., Schumacher, J., Rugo, H. S., Barbls, D., Stall, A. M., Cupp, J., Moore, K. W., et al. (1990) · International Immunology · doi:10.1093/intimm/2.9.821 · Cited by 344
Vicari, A. P., Chiodoni, C., Vaure, C., Aït-Yahia, S., Dercamp, C., Matsos, F., Reynard, O., Taverne, C., Merle, P., Colombo, M. P., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020732 · Cited by 343
Kim, J., Modlin, R. L., Moy, R. L., Dubinett, S. M., McHugh, T. M., Nickoloff, B. J., & Uyemura, K. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.4.2240 · Cited by 323
Dennis, K. L., Wang, Y., Blatner, N. R., Wang, S., Saadalla, A. M., Trudeau, E., Roers, A., Weaver, C. T., Lee, J. J., Gilbert, J. A., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1511 · Cited by 318
Self-citationSanto, C. D., Arscott, R., Booth, S., Karydis, I., Jones, M., Asher, R. G., Salio, M., Middleton, M. R., & Cerundolo, V. (2010) · Nature Immunology · doi:10.1038/ni.1942 · Cited by 316
Shafiani, S., Tucker-Heard, G., Kariyone, A., Takatsu, K., & Urdahl, K. B. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20091885 · Cited by 316
Plaen, E. D., Lurquin, C., Pel, A. V., Mariamé, B., Szikora, J., Wölfel, T., Sibille, C., Chomez, P., & Boon, T. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.7.2274 · Cited by 309
CD4+ CD25+ Regulatory T Lymphocytes Inhibit Microbially Induced Colon Cancer in Rag2-Deficient Mice
Erdman, S. E., Poutahidis, T., Tomczak, M. F., Rogers, A. B., Cormier, K. S., Plank, B., Horwitz, B. H., & Fox, J. G. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63863-1 · Cited by 303
den Eynde, B. J. V., Lethé, B., Pel, A. V., Plaen, E. D., & Boon, T. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.173.6.1373 · Cited by 298
Human interleukin-10 can directly inhibit T-cell growth
Taga, K., Mostowski, H., & Tosato, G. (1993) · Blood · doi:10.1182/blood.v81.11.2964.2964 · Cited by 288
Boonstra, A., Rajsbaum, R., Holman, M. J., Marques, R., Asselin‐Paturel, C., Pereira, J. P., Bates, E. E. M., Akira, S., Vieira, P., Liu, Y., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.7551 · Cited by 288
Kavanagh, B., O'Brien, S., Lee, D., Hou, Y., Weinberg, V., Rini, B., Allison, J. P., Small, E. J., & Fong, L. (2008) · Blood · doi:10.1182/blood-2007-11-125435 · Cited by 256
Jankovic, D. L., Kullberg, M. C., Hieny, S. E., Caspar, P., Collazo, C. M., & Sher, A. (2002) · Immunity · doi:10.1016/s1074-7613(02)00278-9 · Cited by 252
Mast cells are an essential hematopoietic component for polyp development
Gounaris, E. G., Erdman, S. E., Restaino, C. R., Gurish, M. F., Friend, D. S., Gounari, F., Lee, D. M., Zhang, G., Glickman, J. N., Shin, K., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704620104 · Cited by 251
Self-citationGroux, H., Cottrez, F., Rouleau, M., Mauze, S., Antonenko, S. V., Hurst, S. D., McNeil, T., Bigler, M., Roncarolo, M., & Coffman, R. L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.3.1723 · Cited by 246
D, S. M. M., Marincola, F. M., Rossi, C. R., Nitti, D., & Lise, M. (2003) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2003.11.001 · Cited by 246
Cao, A., Yao, S., Gong, B., Elson, C. O., & Cong, Y. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200955 · Cited by 244
Cell intrinsic mechanisms of T‐cell inhibition and application to cancer therapy
Peggs, K. S., Quezada, S. A., & Allison, J. P. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00649.x · Cited by 232
The significant role of mast cells in cancer
Khazaie, K., Blatner, N. R., Khan, M. W., Gounari, F., Gounaris, E. G., Dennis, K. L., Bonertz, A., Tsai, F., Strouch, M. J., Cheon, E. C., et al. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9286-z · Cited by 230
Self-citationInterleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism.
Zheng, L., Ojcius, D. M., Garaud, F., Roth, C., Maxwell, E., Li, Z., Rong, H., Chen, J., Wang, X., Catino, J. J., et al. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.2.579 · Cited by 230
Edwards, A. D., Manickasingham, S. P., Spörri, R., Diebold, S. S., Schulz, O., Sher, A., Kaisho, T., Akira, S., & Sousa, C. R. E. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.7.3652 · Cited by 229
Type 17 CD8+ T cells display enhanced antitumor immunity
Hinrichs, C. S., Kaiser, A., Paulos, C. M., Cassard, L., Sanchez-Perez, L. A., Heemskerk, B., Wrzesinski, C., Borman, Z. A., Muranski, P. J., & Restifo, N. P. (2009) · Blood · doi:10.1182/blood-2009-02-203935 · Cited by 226
Expression of RORγt Marks a Pathogenic Regulatory T Cell Subset in Human Colon Cancer
Blatner, N. R., Mulcahy, M. F., Dennis, K. L., Scholtens, D. M., Bentrem, D. J., Phillips, J. D., Ham, S., Sandall, B. P., Khan, M. W., Mahvi, D. M., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004566 · Cited by 219
Self-citationChen, H., Liakou, C. I., Kamat, A., Pettaway, C., Ward, J. F., Tang, D. N., Sun, J., Jungbluth, A. A., Troncoso, P., Logothetis, C., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813175106 · Cited by 218
Correale, P., Rotundo, M. S., Vecchio, M. T. D., Remondo, C., Migali, C., Ginanneschi, C., Tsang, K. Y., Licchetta, A., Mannucci, S., Loiacono, L., et al. (2010) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181d32f01 · Cited by 217
Intestinal Effector T Cells in Health and Disease
Maynard, C. L., & Weaver, C. T. (2009) · Immunity · doi:10.1016/j.immuni.2009.08.012 · Cited by 215
Buer, J., Lanoue, A., Franzke, A., Cordier, C., von Boehmer, H., & Sarukhan, A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.2.177 · Cited by 214
Th1/Th2 balance in cancer, transplantation and pregnancy
Shurin, M. R., Lü, L., Kaliński, P., Stewart‐Akers, A. M., & Lotze, M. T. (1999) · Springer Seminars in Immunopathology · doi:10.1007/bf00812261 · Cited by 214
Piconese, S., Gri, G., Tripodo, C., Musio, S., Gorzanelli, A., Frossi, B., Pedotti, R., Pucillo, C. E. M., & Colombo, M. P. (2009) · Blood · doi:10.1182/blood-2009-05-220004 · Cited by 211
CD4+CD25+ Regulatory Lymphocytes Induce Regression of Intestinal Tumors in ApcMin/+ Mice
Erdman, S. E., Sohn, J. J., Rao, V. P., Nambiar, P. R., Ge, Z., Fox, J. G., & Schauer, D. B. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3104 · Cited by 211
Interleukin-10 promotes the maintenance of antitumor CD8+ T-cell effector function in situ
Fujii, S., Shimizu, K., Shimizu, T., & Lotze, M. T. (2001) · Blood · doi:10.1182/blood.v98.7.2143 · Cited by 208
Meyaard, L., Hovenkamp, E., Otto, S. A., & Miedema, F. F. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.8.2776 · Cited by 207
Berman, R. M., Suzuki, T., Tahara, H., Robbins, P. D., Narula, S. K., & Lotze, M. T. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.1.231 · Cited by 205
Seder, R. A., Marth, T., Sieve, M. C., Strober, W., Letterio, J. J., Roberts, A. B., & Kelsall, B. L. (1998) · PubMed · Cited by 202
Detection of dysplastic intestinal adenomas using enzyme-sensing molecular beacons in mice
Marten, K., Bremer, C., Khazaie, K., Sameni, M., Sloane, B. F., Tung, C., & Weissleder, R. (2002) · Gastroenterology · doi:10.1053/gast.2002.30990 · Cited by 200
Self-citationStarting at the Beginning: New Perspectives on the Biology of Mucosal T Cells
Cheroutre, H. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104522 · Cited by 199
Interleukin 10 inhibits T cell alloreaction induced by human dendritic cells
Caux, C., Massacrier, C., Vanbervliet, B., Barthélémy, C., Liu, Y.-J., & Banchereau, J. (1994) · International Immunology · doi:10.1093/intimm/6.8.1177 · Cited by 192
Gounaris, E. G., Blatner, N. R., Dennis, K. L., Magnusson, F. C., Gurish, M. F., Strom, T. B., Beckhove, P., Gounari, F., & Khazaie, K. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0304 · Cited by 192
Self-citationGerosa, F., Nisii, C., Righetti, S., Micciolo, R., Marchesini, M., Cazzadori, A., & Trinchieri, G. (1999) · Clinical Immunology · doi:10.1006/clim.1999.4752 · Cited by 190
Knuth, A. K., Wölfel, T., Klehmann, E., Boon, T., & Büschenfelde, K. H. M. Z. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.8.2804 · Cited by 188
Giovarelli, M., Musiani, P., Modesti, A., Dellabona, P., Casorati, G., Allione, A., Consalvo, M., Cavallo, F., Pierro, F. D., & Giovanni, C. D. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.6.3112 · Cited by 180
Akdiş, C. A., Joss, A., Akdiş, M., Faith, A., & Blaser, K. (2000) · The FASEB Journal · doi:10.1096/fj.99-0874fje · Cited by 180
Regulatory Role of T Cells Producing both Interferon γ and Interleukin 10 in Persistent Infection
Trinchieri, G. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.10.f53 · Cited by 164
Santin, A. D., Hermonat, P. L., Ravaggi, A., Bellone, S., Pecorelli, S. L., Roman, J. J., Parham, G. P., & Cannon, M. J. (2000) · Journal of Virology · doi:10.1128/jvi.74.10.4729-4737.2000 · Cited by 161
On the cellular basis of immunological T cell memory
Bruno, L., Kirberg, J., & von Boehmer, H. (1995) · Immunity · doi:10.1016/1074-7613(95)90077-2 · Cited by 159
Human Transferrin Receptor Gene as a Marker Gene for MR Imaging
Moore, A. V., Josephson, L., Bhorade, R. M., Basilion, J. P., & Weissleder, R. (2001) · Radiology · doi:10.1148/radiol.2211001784 · Cited by 156
Gut Barrier Dysfunction in the ApcMin/+ Mouse Model of Colon Cancer Cachexia
Puppa, M. J., White, J. P., Sato, S., Cairns, M., Baynes, J., & Carson, J. (2011) · Biochimica et Biophysica Acta · doi:10.1016/j.bbadis.2011.08.010 · Cited by 156
Haas, M., Dimmler, A., Hohenberger, W., Grabenbauer, G. G., Niedobitek, G., & Distel, L. V. (2009) · BMC Gastroenterology · doi:10.1186/1471-230x-9-65 · Cited by 154
Antimetastatic and Antitumor Activities of Interleukin 10 in a Murine Model of Breast Cancer
Kundu, N., Beaty, T. L., Jackson, M. J., & Fulton, A. M. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.8.536 · Cited by 154
Seder, R. A., Marth, T., Sieve, M. C., Strober, W., Letterio, J. J., Roberts, A. B., & Kelsall, B. L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.12.5719 · Cited by 153
Abating colon cancer polyposis by Lactobacillus acidophilus deficient in lipoteichoic acid
Khazaie, K., Zadeh, M., Khan, M. W., Bere, P., Gounari, F., Dennis, K., Blatner, N. R., Owen, J. L., Klaenhammer, T. R., & Mohamadzadeh, M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1207230109 · Cited by 151
Self-citationIn colorectal cancer mast cells contribute to systemic regulatory T-cell dysfunction
Blatner, N. R., Bonertz, A., Beckhove, P., Cheon, E. C., Krantz, S. B., Strouch, M. J., Weitz, J., Koch, M., Halverson, A. L., Bentrem, D. J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913683107 · Cited by 144
Self-citationLadoire, S., Arnould, L., Mignot, G., Coudert, B. P., Rébé, C., Chalmin, F., Vincent, J., Bruchard, M., Chauffert, B., Martin, F., et al. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0831-1 · Cited by 137
IL-23 receptor (IL-23R) gene protects against pediatric Crohnʼs disease
Dubinsky, M. C., Wang, D., Picornell, Y., Wrobel, I. T., Katzir, L., Quiros, A., Dutridge, D., Wahbeh, G. T., Silber, G. H., Bahar, R., et al. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20126 · Cited by 136
van den Broek, M. F., Bachmann, M. F., Köhler, G., Barner, M., Escher, R., Zinkernagel, R. M., & Köpf, M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.371 · Cited by 131
Perrier, P., Martínez, F., Locati, M., Bianchi, G., Nebuloni, M., Vago, G., Bazzoni, F., Sozzani, S., Allavena, P., & Mantovani, A. (2003) · Journal of Immunology · doi:10.4049/jimmunol.172.11.7031 · Cited by 130
Modifications of CD8+ T Cell Function during In Vivo Memory or Tolerance Induction
Tanchot, C., Guillaume, S., Delon, J., Bourgeois, C., Franzke, A., Sarukhan, A., Trautmann, A., & Rocha, B. (1998) · Immunity · doi:10.1016/s1074-7613(00)80563-4 · Cited by 130
Control of intestinal homeostasis by regulatory T cells and dendritic cells
Coombes, J. L., & Maloy, K. J. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2007.01.001 · Cited by 127
Sacks, D. L., & Anderson, C. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00185.x · Cited by 126
Sharma, P. K., Saha, P. K., Singh, A. R., Sharma, S. K., Ghosh, B., & Mitra, D. K. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200804-529oc · Cited by 126
The Interleukin‐23 / Interleukin‐17 axis in intestinal inflammation
Maloy, K. J. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.01950.x · Cited by 121
The SLAM family of immune-cell receptors
Veillette, A., & Latour, S. (2003) · Current Opinion in Immunology · doi:10.1016/s0952-7915(03)00041-4 · Cited by 121
The impact of CD4+CD25+ Treg on tumor specific CD8+ T cell cytotoxicity and cancer
Khazaie, K., & von Boehmer, H. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.11.006 · Cited by 121
Self-citationIL-12 induces human T cells secreting IL-10 with IFN-γ
Windhagen, A., Anderson, D. E., Carrizosa, A., Williams, R. E., & Hafler, D. A. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.3.1127 · Cited by 119
Taylor, A., Akdiş, M., Joss, A., Akkoç, T., Wenig, R., Colonna, M., Daigle, I., Flory, E., Blaser, K., & Akdiş, C. A. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.04.004 · Cited by 119
Mechanisms of allergen‐specific immunotherapy
Akdiş, C. A., & Blaser, K. (2000) · Allergy · doi:10.1034/j.1398-9995.2000.00120.x · Cited by 119
B-Cell-Derived IL-10: Production and Function
Burdin, N., Rousset, F., & Banchereau, J. (1997) · Methods · doi:10.1006/meth.1996.0393 · Cited by 115
Petersson, M., Charo, J., Salazar‐Onfray, F., Noffz, G., Mohaupt, M., Qin, Z., Klein, G., Blankenstein, T. J. F., & Kiessling, R. W. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.5.2099 · Cited by 109
Gounaris, E. G., Tung, C., Restaino, C. R., Maehr, R., Köhler, R. H., Joyce, J. A., Plough, H. L., Barrett, T. A., Weissleder, R., & Khazaie, K. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002916 · Cited by 108
Self-citationHLA-G and IL-10 expression in human cancer—different stories with the same message
Urosevic, M., & Dummer, R. (2003) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(03)00024-5 · Cited by 105
Shaw, M. H., Freeman, G. J., Scott, M. F., Fox, B. A., Bzik, D. J., Belkaid, Y., & Yap, G. S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7263 · Cited by 105
IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity.
Lee, M. S., Mueller, R., Wicker, L. S., Peterson, L. B., & Sarvetnick, N. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.6.2663 · Cited by 105
Tsuji‐Takayama, K., Suzuki, M., Yamamoto, M., Harashima, A., Okochi, A., Otani, T., Inoue, T., Sugimoto, A., Toraya, T., Takeuchi, M., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.6.3897 · Cited by 97
IL-12 synergizes with IL-2 and other stimuli in inducing IL-10 production by human T cells
Jeannin, P., Delneste, Y., Seveso, M., Life, P. F., & Bonnefoy, J. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.9.3159 · Cited by 93
Pohl‐Koppe, A., Balashov, K. E., Steere, A. C., Logigian, E. L., & Hafler, D. A. (1998) · PubMed · Cited by 91
Interleukin-10 in the regulation of T cell-induced colitis
Annacker, O., Asseman, C., Read, S., & Powrie, F. M. (2003) · Journal of Autoimmunity · doi:10.1016/s0896-8411(03)00045-3 · Cited by 89
How to improve the immunogenicity of chemotherapy and radiotherapy
Ma, Y., Conforti, R., Aymeric, L., Locher, C., Kepp, O., Kroemer, G., & Zitvogel, L. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9283-2 · Cited by 88
Darrah, P. A., Hegde, S. T., Patel, D. T., Lindsay, R. W. B., Chen, L., Roederer, M., & Seder, R. A. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20092532 · Cited by 86
Kurte, M., López, M. N., Aguirre, A., Escobar, A. F., Aguillón, J. C., Charo, J., Larsen, C. G., Kiessling, R. W., & Salazar‐Onfray, F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.3.1731 · Cited by 85
Pohl‐Koppe, A., Balashov, K. E., Steere, A. C., Logigian, E. L., & Hafler, D. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.4.1804 · Cited by 79
Regulatory T-cell stability and plasticity in mucosal and systemic immune systems
Murai, M., Krause, P., Cheroutre, H., & Kronenberg, M. (2010) · Mucosal Immunology · doi:10.1038/mi.2010.27 · Cited by 74
Coquerelle, C., Oldenhove, G., Acolty, V., Denoeud, J., Vansanten, G., Verdebout, J., Mellor, A. L., Bluestone, J. A., & Moser, M. (2009) · Gut · doi:10.1136/gut.2008.162842 · Cited by 71
Antigenic heterogeneity of a human melanoma tumor detected by autologous CTL clones
Degiovanni, G., Lahaye, T., Hérin, M., Hainaut, P., & Boon, T. (1988) · European Journal of Immunology · doi:10.1002/eji.1830180503 · Cited by 64
Akdiş, C. A., Joss, A., Akdiş, M., & Blaser, K. (2001) · International Archives of Allergy and Immunology · doi:10.1159/000053704 · Cited by 62
Interleukin-12: a cytokine with therapeutic potential in oncology and infectious diseases.
Gately, M. K., Gubler, U., Brunda, M. J., Nadeau, R. R., Anderson, T. D., Lipman, J. M., & Sarmiento, U. M. (1994) · PubMed · Cited by 60
Jinquan, T., Quan, S., Jacobi, H., MADSEN, H. O., Glue, C., Skov, P. S., Malling, H., & Poulsen, L. K. (2000) · Immunology · doi:10.1046/j.1365-2567.2000.00954.x · Cited by 53
Matar, P., Rozados, V. R., Gervasoni, S. I., & Scharovsky, O. G. (2001) · International Immunopharmacology · doi:10.1016/s1567-5769(00)00028-x · Cited by 53
Mumm, J. B., & Oft, M. (2013) · BioEssays · doi:10.1002/bies.201300004 · Cited by 53
Kang, S. S., & Allen, P. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.9.5382 · Cited by 49
Lebson, L. A., Gocke, A. R., Rosenzweig, J. M., Alder, J. K., Civin, C. I., Calabresi, P. A., & Whartenby, K. A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002750 · Cited by 49
IL-10 enhances IL-2-induced proliferation and cytotoxicity by human intestinal lymphocytes
Ebert, E. C. (2000) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2000.01147.x · Cited by 41
Loose, D., Signore, A., Bonanno, E., Vermeersch, H., Dierckx, R., Deron, P. B., & de Wiele, C. V. (2008) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2007.0373 · Cited by 35
Kim, B.-G., Joo, H., Chung, I.-S., Chung, H. Y., Woo, H.-J., & Yun, Y. (2000) · Cancer Immunology Immunotherapy · doi:10.1007/s002620000123 · Cited by 34
IL-10 suppresses CD2-mediated T cell activation via SHP-1
Taylor, A., Verhagen, J., Akkoç, T., Wenig, R., Flory, E., Blaser, K., Akdiş, M., & Akdiş, C. A. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.07.031 · Cited by 32
Current developments with peptide-based human tumor vaccines
Khazaie, K., Bonertz, A., & Beckhove, P. (2009) · Current Opinion in Oncology · doi:10.1097/cco.0b013e328331a78e · Cited by 32
Self-citationTougeron, D., Maby, P., Elie, N., Fauquembergue, É., Pessot, F. L., Cornic, M., Sabourin, J., Michel, P., Frébourg, T., & Latouche, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061001 · Cited by 25
Zhang, H., Stern, J. N. H., & Strominger, J. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813197106 · Cited by 8
Tsuchihashi (2000) · doi:10.1002/1521-4141(200006)30:6
Cited by
Sorted by citations
Melief, C. J. M., van Hall, T., Arens, R., OSSENDORP, F. A., & van der Burg, S. H. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80009 · Cited by 1,192
Rational Design of Immunomodulatory Hydrogels for Chronic Wound Healing
Kharaziha, M., Baidya, A., & Annabi, N. (2021) · Advanced Materials · doi:10.1002/adma.202100176 · Cited by 735
The Evasion Mechanisms of Cancer Immunity and Drug Intervention in the Tumor Microenvironment
Kim, S. K., & Cho, S. W. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.868695 · Cited by 502
Balancing the immune response in the brain: IL-10 and its regulation
Lobo‐Silva, D., Carriche, G. M., Castro, A. G., Roque, S., & Saraiva, M. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0763-8 · Cited by 445
Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches
Tufail, M., Jiang, C., & Li, N. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02280-1 · Cited by 454
Metadata
- Authors
- Dennis, K. L., Blatner, N. R., Gounari, F., & Khazaie, K.
- Affiliations
- Northwestern University (US)
- University of Chicago (US)
- Corresponding author
- Khazaie, Khashayarsha
- Venue
- Current Opinion in Oncology
- Published
- 2013-11
- Volume
- 25
- Issue
- 6
- Pages
- 637-645
- ISSN
- 1040-8746 (ISSN-L)
- PMC
- PMC4322764
- OpenAlex
- W2085138770
- Cited by
- 289
- References
- 189
- Citations by year
- 2026: 13 · 2025: 29 · 2024: 23 · 2023: 16 · 2022: 29 · 2021: 35 · 2020: 33 · 2019: 24 · 2018: 26 · 2017: 18 · 2016: 23 · 2015: 13 · 2014: 7
- FWCI
- 1.25
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Current Opinion in Oncology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA160436)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- IL-10, regulatory T cells, tumor immunology, immunosuppression, T helper cells, tumor surveillance, tumor inflammation, immunostimulation, cancer therapy
- MeSH terms
- Animals, Antigens, Neoplasm, Dendritic Cells, Female, Humans, Immune Tolerance, Lymphocyte Activation, Male, Neoplasms, T-Lymphocyte Subsets, Interleukin-10, Cell Line, Tumor, Cell Proliferation, T-Lymphocytes, Regulatory, Mice, Immunomodulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review